Estrogen Plus Progestin Use Linked With Increased Breast Cancer Incidence and Mortality, Los Angeles Biomedical Research Institute Study
4/1/2013 7:29:10 AM
Estrogen plus progestin use is linked with increased breast cancer incidence. In addition, prognosis is similar for both users and nonusers of combined hormone therapy, suggesting that mortality from breast cancer may be higher for hormone therapy users as well, according to a study published March 29 in the Journal of the National Cancer Institute.
comments powered by